More high-quality research needed to make recommendation for use of ¹³¹I-MIBG therapy for newly diagnosed HR NBL https://t.co/VVYub44g1M https://t.co/LNpmkg3myP
RT @Cochrane_Child: New #CochraneEvidence: Iodine-131-meta-iodobenzylguanidine therapy for patients w/ newly diagnosed neuroblastoma https:…
No RCTs or CCTs comparing effectiveness of tx including ¹³¹I-MIBG therapy vs tx not including in patients w/ HR NBL https://t.co/VVYub44g1M https://t.co/VeB9YSjz0g
More high-quality research needed to make recommendation for use of ¹³¹I-MIBG therapy for newly diagnosed HR NBL https://t.co/VVYub44g1M https://t.co/TYbwSJPwBN
RT @Cochrane_Child: New #CochraneEvidence: Iodine-131-meta-iodobenzylguanidine therapy for patients w/ newly diagnosed neuroblastoma https:…
RT @Cochrane_Child: New #CochraneEvidence: Iodine-131-meta-iodobenzylguanidine therapy for patients w/ newly diagnosed neuroblastoma https:…
RT @Cochrane_Child: New #CochraneEvidence: Iodine-131-meta-iodobenzylguanidine therapy for patients w/ newly diagnosed neuroblastoma https:…
RT @Cochrane_Child: New #CochraneEvidence: Iodine-131-meta-iodobenzylguanidine therapy for patients w/ newly diagnosed neuroblastoma https:…
New #CochraneEvidence: Iodine-131-meta-iodobenzylguanidine therapy for patients w/ newly diagnosed neuroblastoma https://t.co/VVYub44g1M https://t.co/XlerrdPWWs
RT @Cochrane_Child: No RCTs or CCTs comparing effectiveness of tx including ¹³¹I-MIBG therapy vs tx not including in patients w/ HR NBL htt…
No RCTs or CCTs comparing effectiveness of tx including ¹³¹I-MIBG therapy vs tx not including in patients w/ HR NBL https://t.co/VVYub44g1M https://t.co/jO1WZa29Ak
New #CochraneEvidence: Iodine-131-meta-iodobenzylguanidine therapy for patients w/ newly diagnosed neuroblastoma https://t.co/VVYub44g1M https://t.co/z9VvCxPxSp
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma. https://t.co/6OwABmy4mE
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk… https://t.co/P44VVzMDh0
CochraneLibrary: Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk… https://t.co/Fbl2XmZSXI https://t.co/7WjXwObG5w